These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
812 related articles for article (PubMed ID: 34782609)
21. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis. Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423 [TBL] [Abstract][Full Text] [Related]
22. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection. Fuentes-Prior P J Biol Chem; 2021; 296():100135. PubMed ID: 33268377 [TBL] [Abstract][Full Text] [Related]
23. ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain. Torre-Fuentes L; Matías-Guiu J; Hernández-Lorenzo L; Montero-Escribano P; Pytel V; Porta-Etessam J; Gómez-Pinedo U; Matías-Guiu JA J Med Virol; 2021 Feb; 93(2):863-869. PubMed ID: 32691890 [TBL] [Abstract][Full Text] [Related]
24. N-glycosylation of the SARS-CoV-2 spike protein at Asn331 and Asn343 is involved in spike-ACE2 binding, virus entry, and regulation of IL-6. Das T; Luo S; Tang H; Fang J; Mao Y; Yen HH; Dash S; Shajahan A; Pepi L; Huang S; Jones VS; Xie S; Huang GF; Lu J; Anderson B; Zhang B; Azadi P; Huang RP Microbiol Immunol; 2024 May; 68(5):165-178. PubMed ID: 38444370 [TBL] [Abstract][Full Text] [Related]
25. ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner. Isobe A; Arai Y; Kuroda D; Okumura N; Ono T; Ushiba S; Nakakita SI; Daidoji T; Suzuki Y; Nakaya T; Matsumoto K; Watanabe Y Commun Biol; 2022 Nov; 5(1):1188. PubMed ID: 36335195 [TBL] [Abstract][Full Text] [Related]
26. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection. Zhuang MW; Cheng Y; Zhang J; Jiang XM; Wang L; Deng J; Wang PH J Med Virol; 2020 Nov; 92(11):2693-2701. PubMed ID: 32497323 [TBL] [Abstract][Full Text] [Related]
28. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor. Lata S; Akif M J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980 [TBL] [Abstract][Full Text] [Related]
29. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19. Kuba K; Yamaguchi T; Penninger JM Front Immunol; 2021; 12():732690. PubMed ID: 35003058 [TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 variant Omicron (B.1.1.529) is in a rising trend of mutations increasing the positive electric charge in crucial regions of the spike protein S. Pawłowski P Acta Biochim Pol; 2021 Dec; 69(1):263-264. PubMed ID: 34905671 [TBL] [Abstract][Full Text] [Related]
31. Human ACE2 Polymorphisms from Different Human Populations Modulate SARS-CoV-2 Infection. Hu P; Bauer VL; Sawyer SL; Diaz-Griffero F Viruses; 2022 Jun; 14(7):. PubMed ID: 35891433 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts. Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529 [TBL] [Abstract][Full Text] [Related]
33. Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features. Hassan SS; Ghosh S; Attrish D; Choudhury PP; Aljabali AAA; Uhal BD; Lundstrom K; Rezaei N; Uversky VN; Seyran M; Pizzol D; Adadi P; Soares A; El-Aziz TMA; Kandimalla R; Tambuwala MM; Azad GK; Sherchan SP; Baetas-da-Cruz W; Takayama K; Serrano-Aroca Á; Chauhan G; Palu G; Brufsky AM Molecules; 2020 Dec; 25(24):. PubMed ID: 33322198 [TBL] [Abstract][Full Text] [Related]
34. Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective. Borkotoky S; Dey D; Hazarika Z Mol Biol Rep; 2023 Mar; 50(3):2713-2721. PubMed ID: 36562937 [TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells. Zheng L; Ma Y; Chen M; Wu G; Yan C; Zhang XE Biochem Biophys Res Commun; 2021 Nov; 579():69-75. PubMed ID: 34592572 [TBL] [Abstract][Full Text] [Related]
36. The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies. Papageorgiou AC; Mohsin I Cells; 2020 Oct; 9(11):. PubMed ID: 33105869 [TBL] [Abstract][Full Text] [Related]
38. ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues. Badawi S; Ali BR Hum Genomics; 2021 Jan; 15(1):8. PubMed ID: 33514423 [TBL] [Abstract][Full Text] [Related]
39. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA Elife; 2021 Aug; 10():. PubMed ID: 34435953 [TBL] [Abstract][Full Text] [Related]
40. The TRAF3-DYRK1A-RAD54L2 complex maintains ACE2 expression to promote SARS-CoV-2 infection. Mao D; Liu S; Phan AT; Renner S; Sun Y; Wang TT; Zhu Y J Virol; 2024 May; 98(5):e0034724. PubMed ID: 38651897 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]